ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
Launched by UNIVERSITY HOSPITAL OF FERRARA · Mar 19, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The ConTempoRary Cardiac Stimulation study is looking at how well different methods of implanting pacemakers and defibrillators work for patients with heart rhythm problems. The researchers want to understand the safety and effectiveness of these procedures and see how advanced imaging techniques can help during the implantation process. This is important because it can lead to better care for patients with conditions like heart failure, arrhythmias, and other issues that affect the heart's ability to pump blood effectively.
To join this study, participants need to be at least 18 years old and have a medical reason to receive a pacemaker or defibrillator. If you decide to participate, you'll receive a permanent device to help manage your heart condition, and the doctors will closely monitor the procedure to ensure everything goes smoothly. This research is still looking for volunteers, and it aims to improve treatment options for many people with serious heart issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Indication for cardiac stimulation
- • Having performed the implantation of a device for cardiac stimulation
- Exclusion Criteria:
- • Age \< 18 years;
- • Pregnancy status;
About University Hospital Of Ferrara
The University Hospital of Ferrara, a leading academic medical institution in Italy, is dedicated to advancing healthcare through innovative research and clinical excellence. Affiliated with the University of Ferrara, the hospital is known for its commitment to integrating cutting-edge scientific inquiry with patient care. With a multidisciplinary approach, the institution conducts a wide range of clinical trials aimed at enhancing treatment methodologies and improving patient outcomes in various medical fields. The University Hospital of Ferrara prioritizes ethical standards and patient safety, fostering a collaborative environment that engages researchers, healthcare professionals, and patients in the pursuit of medical advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Empoli, , Italy
Ravenna, , Italy
Firenze, , Italy
Modena, , Italy
Arezzo, , Italy
Pisa, , Italy
Cesena, , Italy
Siena, , Italy
Firenze, , Italy
Palermo, , Italy
Fidenza, , Italy
Lucca, , Italy
Forlì, , Italy
Ferrara, Fe, Italy
Bologna, , Italy
Bologna, , Italy
Carpi, , Italy
Cento, , Italy
Firenze, , Italy
Foggia, , Italy
Grosseto, , Italy
Lido Di Camaiore, , Italy
Livorno, , Italy
Massa, , Italy
Modena, , Italy
Palermo, , Italy
Parma, , Italy
Piacenza, , Italy
Pisa, , Italy
Reggio Emilia, , Italy
Rimini, , Italy
Patients applied
Trial Officials
Matteo Bertini, MD, PhD
Principal Investigator
Azienda Ospedaliero Universitaria di Ferrara
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported